Table 2.
Multivariate analysis of oncologic patients with COVID-19.
| Death | Odds ratio | p > |z| | 95% Confidence interval | |
|---|---|---|---|---|
| Age | 1.003 | 0.769 | 0.98 | 1.03 |
| Sex | ||||
| Female | 0.42 | 0.031 | 0.19 | 0.92 |
| Male | Ref. | |||
| ECOG | ||||
| Low functionality | 5.42 | 0.0001 | 2.41 | 12.16 |
| High functionality | Ref. | |||
| Tobacco use | ||||
| Yes | 1.33 | 0.496 | 0.58 | 3.07 |
| No | Ref. | |||
| Diabetes mellitus | ||||
| Yes | 1.13 | 0.807 | 0.43 | 2.94 |
| No | Ref. | |||
| Chronic kidney disease | ||||
| Yes | 1.99 | 0.472 | 0.30 | 13.05 |
| No | Ref. | |||
| Clinical stage | ||||
| Advanced | 0.85 | 0.696 | 0.39 | 1.87 |
| Non-advanced | Ref. | |||
| Oncologic diagnosis | ||||
| Hematologic | 0.83 | 0.717 | 0.30 | 2.29 |
| Solid | Ref. | |||
| Treatment | ||||
| Without treatment | 1.88 | 0.234 | 0.67 | 5.30 |
| Ongoing treatment | Ref. | |||
| Cancer status | ||||
| Active disease | 3.94 | 0.041 | 1.05 | 14.73 |
| Disease in remittance | Ref. | |||
| COVID-19 symptoms | ||||
| Cough | ||||
| Yes | 1.82 | 0.186 | 0.75 | 4.42 |
| No | Ref. | |||
| Fever | ||||
| Yes | 1.47 | 0.376 | 0.63 | 3.46 |
| No | Ref. | |||
| Dyspnea | ||||
| Yes | 2.49 | 0.027 | 1.10 | 5.59 |
| No | Ref. | |||
| Nausea | ||||
| Yes | 4.03 | 0.028 | 1.17 | 13.97 |
| No | Ref. | |||
| Vomiting | ||||
| Yes | 0.74 | 0.682 | 0.17 | 3.12 |
| No | Ref. | |||
| Abdominal pain | ||||
| Yes | 0.65 | 0.444 | 0.22 | 1.94 |
| No | Ref. | |||
| Rhinorrhea | ||||
| Yes | 1.43 | 0.44 | 0.57 | 3.58 |
| No | Ref. | |||
| Myalgia | ||||
| Yes | 0.40 | 0.17 | 0.11 | 1.48 |
| No | Ref. | |||
| Arthralgia | ||||
| Yes | 2.54 | 0.16 | 0.68 | 9.51 |
| No | Ref. | |||
| Oxygen saturation (%) | 0.90 | 0.0001 | 0.87 | 0.94 |
COVID-19, coronavirus disease 2019; ECOG, Eastern Cooperative Oncology Group; Ref, reference category.
The bold values represent p < 0.05.